Opioid Agonist Treatment: December 2019
The Correctional Service of Canada (CSC) introduced methadone over 20 years ago. Since that time, CSC has been providing opioid agonist treatment (OAT) (methadone and buprenorphine-naloxone) to incarcerated persons with an opioid use disorder.
Over the past three years, in the context of the Canadian opioid crisis, the demand for treatment has dramatically increased and continues to increase. The following graph shows a point-in-time snapshot (December 2019) of the number of individuals, by institution, on OAT and the number of individuals on the wait list.
The categories are: methadone, suboxone, sublocade, Opioid Agonist Treatment (OAT) total and waitlist. For the Atlantic region: For the Quebec region: For the Ontario Region: For the Prairies region: For the Pacific Region: In total, there are 770 on methadone, 1047 on suboxone, 38 on sublocade. The OAT totals are 1855 and there are 460 on waitlist.
Download a printable version of the December 2019 OAT graph.
Page details
- Date modified: